<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nid</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология и диализ</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology and Dialysis</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1680-4422</issn><issn pub-type="epub">2618-9801</issn><publisher><publisher-name>Российское диализное общество</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">nid-819</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Морфологические особенности позднего отторжения трансплантированной почки и их влияние на течение и прогноз нефропатии</article-title><trans-title-group xml:lang="en"><trans-title>Late kidney allograft rejection: the impact of pathology on the long-term outcome</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Столяревич</surname><given-names>Е. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Stolyarevich</surname><given-names>E. S.</given-names></name></name-alternatives><email xlink:type="simple">stolyarevich@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Артюхина</surname><given-names>Л. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Artyuhina</surname><given-names>L. Y.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ким</surname><given-names>И. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Kim</surname><given-names>I. G.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Куренкова</surname><given-names>Л. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Kurenkova</surname><given-names>L. G.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Томилина</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Tomilina</surname><given-names>N. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-4"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГУ «ФНЦ Трансплантологии и искусственных органов им. академика В.И. Шумакова» МЗ и СР РФ; Кафедра нефрологии ФПДО МГМСУ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V.I. Shumakov Federal Scientific Center of Transplantology and artificial organs of Russian Health Ministry, Moscow; Department of Nephrology, Moscow Medical-dental University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ГКБ № 52 г. Москва</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Moscow City hospital No 52</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГУ «ФНЦ Трансплантологии и искусственных органов им. академика В.И. Шумакова» МЗ и СР РФ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V.I. Shumakov Federal Scientific Center of Transplantology and artificial organs of Russian Health Ministry, Moscow</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>ФГУ «ФНЦ Трансплантологии и искусственных органов им. академика В.И. Шумакова» МЗ и СР РФ; Кафедра нефрологии ФПДО МГМСУ; ГКБ № 52 г. Москва</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V.I. Shumakov Federal Scientific Center of Transplantology and artificial organs of Russian Health Ministry, Moscow; Department of Nephrology, Moscow Medical-dental University; Moscow City hospital No 52</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2012</year></pub-date><pub-date pub-type="epub"><day>17</day><month>06</month><year>2025</year></pub-date><volume>14</volume><issue>4</issue><fpage>242</fpage><lpage>252</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Столяревич Е.С., Артюхина Л.Ю., Ким И.Г., Куренкова Л.Г., Томилина Н.А., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Столяревич Е.С., Артюхина Л.Ю., Ким И.Г., Куренкова Л.Г., Томилина Н.А.</copyright-holder><copyright-holder xml:lang="en">Stolyarevich E.S., Artyuhina L.Y., Kim I.G., Kurenkova L.G., Tomilina N.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephro.ru/jour/article/view/819">https://journal.nephro.ru/jour/article/view/819</self-uri><abstract><p>Отторжение трансплантата остается одной из наиболее частых причин дисфункции почечного трансплантата в поздние сроки после АТП. Целью настоящего исследования было проанализировать частоту встречаемости различных вариантов позднего отторжения трансплантата, выявить особенности их клинических проявлений и течения, а также определить морфологические и клинические факторы, определяющие прогноз нефропатии при различных типах позднего отторжения трансплантата. Проанализированы материалы 265 пациентов, которым в связи с поздней дисфункцией почечного трансплантата было выполнено 294 биопсии (в среднем через 48,8 ± 46,1 мес. после АТП), на основании чего верифицирован диагноз острого (n = 194) или хронического (n = 78) отторжения трансплантата либо (в 22 случаях) их сочетание. Свечение C4d выявлялось в 34% случаев острого отторжения и в 59% случаев при ХОТ (в том числе при ХТГ – 65%, при васкулопатии – 50%). 5-летняя выживаемость трансплантатов составила 48, 34 и 17% при ООТ, ХОТ и сочетании ООТ+ХОТ соответственно (p &lt; 0,01). При этом в случаях острого отторжения прогноз C4d+ форм был хуже, чем в отсутствие свечения C4d (53% v s 33%; p = 0,002), тогда как при хроническом отторжении подобная закономерность отсутствовала (36% vs 34%; p = NS). В многофакторной модели Кокса прогностическое значение имели ХТГ, признаки васкулита, распространенность интерстициального фиброза и плазмаклеточный характер инфильтрата. Из клинических факторов наибольшее прогностическое значение имела выраженность дисфункции трансплантата: повышение креатинина крови на каждые 0,1 ммоль/л увеличивает вероятность неблагоприятного исхода отторжения на 60%. В зависимости от исходного Pcr (&lt;0,2; 0,2–0,3; 0,3–0,4; &gt;0,4 ммоль/л) 2-летняя выживаемость трансплантата при остром отторжении составляла 97,5; 78,5; 67,8 и 20,7%, тогда как при ХОТ эти показатели составили 75; 33,9; 20,8 и 0% соответственно, то есть при уровне креатинина более 0,2 ммоль/л, у большинства пациентов с ХОТ рецидив терминальной ХПН развивался уже в первые 2 года с момента диагностики отторжения, что определяет необходимость максимально ранней диагностики и лечения этой патологии.</p></abstract><trans-abstract xml:lang="en"><p>Rejection has always been one of the most important cause of late renal graft dysfunction. The aim of the study was to analyze the prevalence of different clinical and pathological variants of rejection that cause late graft dysfunction and to evaluate their impact on long-term outcome. A retrospective study included 294 needle core biopsy specimens from 265 renal transplant recipients with late (48,8 ± 46,1 months after transplantation) allograft dysfunction caused by late acute rejection (LAR n = 194) or chronic rejection (CR n = 78) or both (n = 22). C4d staining was performed by immunofluorescence (IF) on frozen sections using a standard protocol. Peritubular capillary C4d deposition was identified in 34% samples with acute rejection and in 59% cases of chronic rejection (65% cases of transplant glomerulopathy, and 50% of isolated chronic vasculopathy). 5-year graft survival for LAR vs CR vs combination were 48%, 34% и 17%, respectively. The outcome of C4d+ LAR was better (p &lt; 0,01) than of C4d+ acute rejection: at 60 months, graft survival for diffuse C4d+ vs focal C4d+ vs C4d– were 29% vs 51% vs 43%, respectively. In cases of chronic rejection C4d+ vs C4d– was not statistically significant (34% vs 36%). By multivariate Cox analysis the risk of graft loss was associated with transplant glomerulopathy, intimal arteriitis, widespread interstitial fibrosis and plasma cell-rich infiltrates. Among clinical factors serum creatinine had a strongest impact on graft outcome: using Cox regression, the hazard ratio of graft loss was 1,6 (1,42–1,79) for each 0,1 mmol/l (p = 0,017). 5-year graft survival according to the initial serum creatinine were 97,5; 78,5; 67,8 and 20,7% for &lt;0,2; 0,2–0,3; 0,3–0,4; &gt;0,4 mmol/l respectively for LAR and 75; 33,9; 20,8 and 0% for CR. Proteinuria &gt;3 g/d was a poor prognostic factor for LAR. No statistically significant difference was found for proteinuria vs mild to moderate urine protein level. In contrast for CR recipients only the absence of proteinuria had a significant positive impact on graft outcome compared with mild moderate or heavy proteinuria.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>kidney transplantation</kwd><kwd>late acute rejection</kwd><kwd>chronic rejection</kwd><kwd>трансплантация почки</kwd><kwd>острое позднее отторжение</kwd><kwd>хроническое отторжение</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Ciszek M., Ptasińska A.P., Durlik M. et al. C4d-positive renal transplants: single-center clinical outcomes // Clin. Transpl. 2006. Vol. 1. Р. 405–412.</mixed-citation><mixed-citation xml:lang="en">Ciszek M., Ptasińska A.P., Durlik M. et al. C4d-positive renal transplants: single-center clinical outcomes // Clin. Transpl. 2006. Vol. 1. Р. 405–412.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Collins A.B., Schneeberger E.E., Pascual M.A. et al. Complement activation in acute humoral renal allograft rejection: Significance of C4d deposits in peritubular capillaries // J. Am. Soc. Nephrol. 1999. Vol. 10. P. 2208–2214.</mixed-citation><mixed-citation xml:lang="en">Collins A.B., Schneeberger E.E., Pascual M.A. et al. Complement activation in acute humoral renal allograft rejection: Significance of C4d deposits in peritubular capillaries // J. Am. Soc. Nephrol. 1999. Vol. 10. P. 2208–2214.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Colvin R.B. Renal transplant pathology. In: Heptinstall’s Pathology of the Kidney, 5th Ed. / ed. by Jennette J.C., Olson J.C., Schwartz M.L., Silva F.G. Philadelphia. Lippincott-Raven Publishers, 1998. Р. 1409–1540.</mixed-citation><mixed-citation xml:lang="en">Colvin R.B. Renal transplant pathology. In: Heptinstall’s Pathology of the Kidney, 5th Ed. / ed. by Jennette J.C., Olson J.C., Schwartz M.L., Silva F.G. Philadelphia. Lippincott-Raven Publishers, 1998. Р. 1409–1540.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Cosio F.G., Grande J.P., Wadei H. et al. Predicting subsequent decline in kidney allograft function from early surveillance biopsies // Am. J. Transplant. 2005. Vol. 5. P. 2464–2472.</mixed-citation><mixed-citation xml:lang="en">Cosio F.G., Grande J.P., Wadei H. et al. Predicting subsequent decline in kidney allograft function from early surveillance biopsies // Am. J. Transplant. 2005. Vol. 5. P. 2464–2472.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Crespo M., Pascual M., Tolkoff-Rubin N. et al. Acute humoral rejection in renal allograft recipients: Incidence, serology, and clinical characteristics // Transplantation. 2001. Vol. 71. Р. 652–658.</mixed-citation><mixed-citation xml:lang="en">Crespo M., Pascual M., Tolkoff-Rubin N. et al. Acute humoral rejection in renal allograft recipients: Incidence, serology, and clinical characteristics // Transplantation. 2001. Vol. 71. Р. 652–658.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">David-Neto E., Prado E., Beutel A. et al. C4d-positive chronic rejection: A frequent entity with a poor outcome // Transplantation. 2007. Vol. 84. P. 1391–1398.</mixed-citation><mixed-citation xml:lang="en">David-Neto E., Prado E., Beutel A. et al. C4d-positive chronic rejection: A frequent entity with a poor outcome // Transplantation. 2007. Vol. 84. P. 1391–1398.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Feucht H.E., Felber E., Gokel M.J. et al. Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection // Clin. Exp. Immunol. 1991. Vol. 86. P. 464–470.</mixed-citation><mixed-citation xml:lang="en">Feucht H.E., Felber E., Gokel M.J. et al. Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection // Clin. Exp. Immunol. 1991. Vol. 86. P. 464–470.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Feucht H.E., Schneeberger H., Hillebrand G. et al. Capillary deposition of C4d complement fragment and early renal graft loss // Kidney Int. 1993. Vol. 43. P. 1333–1338.</mixed-citation><mixed-citation xml:lang="en">Feucht H.E., Schneeberger H., Hillebrand G. et al. Capillary deposition of C4d complement fragment and early renal graft loss // Kidney Int. 1993. Vol. 43. P. 1333–1338.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Gaston R.S., Cecka J.M., Kasiske B.L. et al. Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure // Transplantation. 2010. Vol. 90 (1). P. 68–74.</mixed-citation><mixed-citation xml:lang="en">Gaston R.S., Cecka J.M., Kasiske B.L. et al. Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure // Transplantation. 2010. Vol. 90 (1). P. 68–74.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Gloor J.M., Sethi S., Stegall M.D. Transplant Glomerulopathy: Subclinical Incidence and Association with Alloantibody // American Journal of Transplantation. 2007. Vol. 7. P. 2124–2132.</mixed-citation><mixed-citation xml:lang="en">Gloor J.M., Sethi S., Stegall M.D. Transplant Glomerulopathy: Subclinical Incidence and Association with Alloantibody // American Journal of Transplantation. 2007. Vol. 7. P. 2124–2132.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Gourishankar S., Leduc R., Connett J. et al. Pathological and clinical characterization of the “troubled transplant”: data from the DeKAF study // Am. J. Transplant. 2010 Vol. 10 (2). P. 324–330.</mixed-citation><mixed-citation xml:lang="en">Gourishankar S., Leduc R., Connett J. et al. Pathological and clinical characterization of the “troubled transplant”: data from the DeKAF study // Am. J. Transplant. 2010 Vol. 10 (2). P. 324–330.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Haas M. C4d-negative antibody-mediated rejection in renal allografts: evidence for its existence and effect on graft survival // Clinical Nephrology. 2011. Vol. 75. P. 271–278.</mixed-citation><mixed-citation xml:lang="en">Haas M. C4d-negative antibody-mediated rejection in renal allografts: evidence for its existence and effect on graft survival // Clinical Nephrology. 2011. Vol. 75. P. 271–278.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Haas M. Pathologic features of antibody-mediated rejection in renal allografts: an expanding spectrum // Curr. Opin. Nephrol. Hypertens. 2012. Vol. 21 (3). P. 264–271.</mixed-citation><mixed-citation xml:lang="en">Haas M. Pathologic features of antibody-mediated rejection in renal allografts: an expanding spectrum // Curr. Opin. Nephrol. Hypertens. 2012. Vol. 21 (3). P. 264–271.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Herzenberg A.M., Gill J.S., Djurdjev O., Magil A.B. C4d deposition in acute rejection: An independent long-term prognostic factor // J. Am. Soc. Nephrol. 2002. Vol. 13. P. 234–241.</mixed-citation><mixed-citation xml:lang="en">Herzenberg A.M., Gill J.S., Djurdjev O., Magil A.B. C4d deposition in acute rejection: An independent long-term prognostic factor // J. Am. Soc. Nephrol. 2002. Vol. 13. P. 234–241.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Hidalgo L.G., Sis B., Sellares J. et al. NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection // Am. J. Transplant. 2010. Vol. 10 (8). P. 1812–1822.</mixed-citation><mixed-citation xml:lang="en">Hidalgo L.G., Sis B., Sellares J. et al. NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection // Am. J. Transplant. 2010. Vol. 10 (8). P. 1812–1822.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Joseph J.T., Kingsmore D.B., Junor B.J. et al. The impact of late acute rejection after cadaveric kidney transplantation // Clin. Transplant. 2001. Vol. 15. Р. 221–227.</mixed-citation><mixed-citation xml:lang="en">Joseph J.T., Kingsmore D.B., Junor B.J. et al. The impact of late acute rejection after cadaveric kidney transplantation // Clin. Transplant. 2001. Vol. 15. Р. 221–227.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Kedainis R.L., Koch M.J., Brennan D.C., Liapis H. Focal C4d+ in Renal Allografts is Associated with the Presence of Donor Specific Antibodies and Decreased Allograft Survival // Am. J. Transplant. 2009. Vol. 9 (4). P. 812–819.</mixed-citation><mixed-citation xml:lang="en">Kedainis R.L., Koch M.J., Brennan D.C., Liapis H. Focal C4d+ in Renal Allografts is Associated with the Presence of Donor Specific Antibodies and Decreased Allograft Survival // Am. J. Transplant. 2009. Vol. 9 (4). P. 812–819.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Kieran N., Wang X., Perkins J. et al. Combination of Peritubular C4d and Transplant Glomerulopathy Predicts Late Renal Allograft Failure // J. Am. Soc. Nephrol. 2009. Vol. 20 (10). P. 2260–2268.</mixed-citation><mixed-citation xml:lang="en">Kieran N., Wang X., Perkins J. et al. Combination of Peritubular C4d and Transplant Glomerulopathy Predicts Late Renal Allograft Failure // J. Am. Soc. Nephrol. 2009. Vol. 20 (10). P. 2260–2268.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Loupy A., Hill G.S., Suberbielle C. et al. Significance of C4d Banff Scores in Early Protocol Biopsies of Kidney Transplant Recipients with Preformed Donor-Specific Antibodies (DSA) // Am. J. Transplant. 2011. Vol. 11. P. 56–65.</mixed-citation><mixed-citation xml:lang="en">Loupy A., Hill G.S., Suberbielle C. et al. Significance of C4d Banff Scores in Early Protocol Biopsies of Kidney Transplant Recipients with Preformed Donor-Specific Antibodies (DSA) // Am. J. Transplant. 2011. Vol. 11. P. 56–65.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Magil A.B., Tinckam K.J. Focal peritubular capillary C4d deposition in acute rejection // Nephrol. Dial. Transplant. 2006. Vol. 21. P. 1382–1388.</mixed-citation><mixed-citation xml:lang="en">Magil A.B., Tinckam K.J. Focal peritubular capillary C4d deposition in acute rejection // Nephrol. Dial. Transplant. 2006. Vol. 21. P. 1382–1388.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Mauiyyedi S., Crespo M., Collins A.B. et al. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification // J. Am. Soc. Nephrol. 2002. Vol. 13. P. 779 –787.</mixed-citation><mixed-citation xml:lang="en">Mauiyyedi S., Crespo M., Collins A.B. et al. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification // J. Am. Soc. Nephrol. 2002. Vol. 13. P. 779 –787.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Mauiyyedi S., Pelle P.D., Saidman S. et al. Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposition in peritubular capillaries // J. Am. Soc. Nephrol. 2001. Vol. 12. P. 574–582.</mixed-citation><mixed-citation xml:lang="en">Mauiyyedi S., Pelle P.D., Saidman S. et al. Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposition in peritubular capillaries // J. Am. Soc. Nephrol. 2001. Vol. 12. P. 574–582.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Mengel M., Bogers J., Bosmans J.L. et al. Incidence of C4d stain in protocol biopsies from renal allografts: results from a multicenter trial // Am. J. Transplant. 2005. Vol. 5. P. 1050–1056.</mixed-citation><mixed-citation xml:lang="en">Mengel M., Bogers J., Bosmans J.L. et al. Incidence of C4d stain in protocol biopsies from renal allografts: results from a multicenter trial // Am. J. Transplant. 2005. Vol. 5. P. 1050–1056.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Miura M., Harada H., Fukasawa Y. Long-term histopathology of allografts in sensitized kidney recipients // Clin. Transplant. 2012. Vol. 26. Suppl. 24. P. 32–36.</mixed-citation><mixed-citation xml:lang="en">Miura M., Harada H., Fukasawa Y. Long-term histopathology of allografts in sensitized kidney recipients // Clin. Transplant. 2012. Vol. 26. Suppl. 24. P. 32–36.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Nankivell B.J., Alexander S.I. Rejection of the Kidney Allograft // N. Engl. J. Med. 2010. Vol. 363. P. 1451–1462.</mixed-citation><mixed-citation xml:lang="en">Nankivell B.J., Alexander S.I. Rejection of the Kidney Allograft // N. Engl. J. Med. 2010. Vol. 363. P. 1451–1462.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Nankivell B.J., Chapman J.R. Chronic allograft nephropathy: current concepts and future directions // Transplantation. 2006. Vol. 81. Р. 643–654.</mixed-citation><mixed-citation xml:lang="en">Nankivell B.J., Chapman J.R. Chronic allograft nephropathy: current concepts and future directions // Transplantation. 2006. Vol. 81. Р. 643–654.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Nickeleit V., Andreoni K. The classification and treatment of antibody-mediated renal allograft injury: Where do we stand? // Kidney Int. 2007. Vol. 71. P. 7–11.</mixed-citation><mixed-citation xml:lang="en">Nickeleit V., Andreoni K. The classification and treatment of antibody-mediated renal allograft injury: Where do we stand? // Kidney Int. 2007. Vol. 71. P. 7–11.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Nickeleit V., Zeiler M., Gudat F. et al. Detection of the complement degradation product C4d in renal allografts: diagnostic and therapeutic implications // J. Am. Soc. Nephrol. 2002. Vol. 13. Р. 242–251.</mixed-citation><mixed-citation xml:lang="en">Nickeleit V., Zeiler M., Gudat F. et al. Detection of the complement degradation product C4d in renal allografts: diagnostic and therapeutic implications // J. Am. Soc. Nephrol. 2002. Vol. 13. Р. 242–251.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Pefaur J., Diaz P., Panace R. et al. Early and late humoral rejection: a clinicopathologic entity in two times // Transplant. Proc. 2008. Vol. 40. Р. 3229–3236.</mixed-citation><mixed-citation xml:lang="en">Pefaur J., Diaz P., Panace R. et al. Early and late humoral rejection: a clinicopathologic entity in two times // Transplant. Proc. 2008. Vol. 40. Р. 3229–3236.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Plissonier D., Henaff M., Poncet P. et al. Involvement of antibody-dependent apoptosis in graft rejection // Transplantation. 2000. Vol. 69. P. 2601–2608.</mixed-citation><mixed-citation xml:lang="en">Plissonier D., Henaff M., Poncet P. et al. Involvement of antibody-dependent apoptosis in graft rejection // Transplantation. 2000. Vol. 69. P. 2601–2608.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Poduval R.D., Kadambi P.V., Josephson M.A. et al. Implications of immunohistochemical detection of C4d along peritubular capillaries in late acute renal allograft rejection // Transplantation. 2005. Vol. 79. P. 228–235.</mixed-citation><mixed-citation xml:lang="en">Poduval R.D., Kadambi P.V., Josephson M.A. et al. Implications of immunohistochemical detection of C4d along peritubular capillaries in late acute renal allograft rejection // Transplantation. 2005. Vol. 79. P. 228–235.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Racusen L. Chronic transplant glomerulopathy: need for further assessment // Clin. J. Am. Soc. Nephrol. 2007 Vol. 2. P. 1108–1109.</mixed-citation><mixed-citation xml:lang="en">Racusen L. Chronic transplant glomerulopathy: need for further assessment // Clin. J. Am. Soc. Nephrol. 2007 Vol. 2. P. 1108–1109.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Racusen L.C., Solez K., Colvin R.B. et al. The Banff 97 working classification of renal allograft pathology // Kidney Int. 1999. Vol. 55. Р. 713–723.</mixed-citation><mixed-citation xml:lang="en">Racusen L.C., Solez K., Colvin R.B. et al. The Banff 97 working classification of renal allograft pathology // Kidney Int. 1999. Vol. 55. Р. 713–723.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Racusen L.C., Colvin R.B., Solez K. et al. Antibody-mediated rejection criteria – an addition to the Banff 97 classification of renal allograft rejection // Am. J. Transplant. 2003. Vol. 3. Р. 708–714.</mixed-citation><mixed-citation xml:lang="en">Racusen L.C., Colvin R.B., Solez K. et al. Antibody-mediated rejection criteria – an addition to the Banff 97 classification of renal allograft rejection // Am. J. Transplant. 2003. Vol. 3. Р. 708–714.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Regele H., Bohmig G.A., Habicht A. et al. Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: A contribution of humoral immunity to chronic allograft rejection // J. Am. Soc. Nephrol. 2002. Vol. 13. P. 2371–2380.</mixed-citation><mixed-citation xml:lang="en">Regele H., Bohmig G.A., Habicht A. et al. Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: A contribution of humoral immunity to chronic allograft rejection // J. Am. Soc. Nephrol. 2002. Vol. 13. P. 2371–2380.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Regele H., Exner M., Watschinger B. et al. Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection // Nephrol. Dial. Transplant. 2001. Vol. 16. P. 2058–2066.</mixed-citation><mixed-citation xml:lang="en">Regele H., Exner M., Watschinger B. et al. Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection // Nephrol. Dial. Transplant. 2001. Vol. 16. P. 2058–2066.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Rotmans S., Collins A.B., Colvin R.B. et al. C4d deposition in allograft: current concepts and interpretation // Transplantation reviews. 2005. Vol. 19. Р. 65–72.</mixed-citation><mixed-citation xml:lang="en">Rotmans S., Collins A.B., Colvin R.B. et al. C4d deposition in allograft: current concepts and interpretation // Transplantation reviews. 2005. Vol. 19. Р. 65–72.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Satoskar A.A., Lehman A.M., Nadasdy G.M. et al. Peritubular capillary C4d staining in late acute renal allograft rejection – is it relevant? // Clin. Transplant. 2008. Vol. 22. Р. 61–67.</mixed-citation><mixed-citation xml:lang="en">Satoskar A.A., Lehman A.M., Nadasdy G.M. et al. Peritubular capillary C4d staining in late acute renal allograft rejection – is it relevant? // Clin. Transplant. 2008. Vol. 22. Р. 61–67.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Shimizu T., Tanabe T., Shirakawa H. et al. Clinical and pathological analysis of transplant glomerulopathy cases // Clin. Transplant. 2012. Vol. 26. P. 37–42.</mixed-citation><mixed-citation xml:lang="en">Shimizu T., Tanabe T., Shirakawa H. et al. Clinical and pathological analysis of transplant glomerulopathy cases // Clin. Transplant. 2012. Vol. 26. P. 37–42.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Sijpkens Y.W., Doxiadis I.I., Mallat M.J. et al. Early versus late acute rejection episodes in renal transplantation // Transplantation. 2003. Vol. 75. Р. 204–208.</mixed-citation><mixed-citation xml:lang="en">Sijpkens Y.W., Doxiadis I.I., Mallat M.J. et al. Early versus late acute rejection episodes in renal transplantation // Transplantation. 2003. Vol. 75. Р. 204–208.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Sis B., Campbell P.M., Mueller T. et al. Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause // Am. J. Transplant. 2007. Vol. 7. P. 1743–1752.</mixed-citation><mixed-citation xml:lang="en">Sis B., Campbell P.M., Mueller T. et al. Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause // Am. J. Transplant. 2007. Vol. 7. P. 1743–1752.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Sis B., Jhangri G.S., Bunnag S. Endothelial gene expression in kidney transplants with alloantibody indicates Antibody-mediated damage despite lack of C4d staining // American Journal of Transplantation. 2009. Vol. 9. P. 2312–2323.</mixed-citation><mixed-citation xml:lang="en">Sis B., Jhangri G.S., Bunnag S. Endothelial gene expression in kidney transplants with alloantibody indicates Antibody-mediated damage despite lack of C4d staining // American Journal of Transplantation. 2009. Vol. 9. P. 2312–2323.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Sis B., Mengel M., Haas M. et al. Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups // Am. J. Transplant. 2010. Vol. 10. P. 464–471.</mixed-citation><mixed-citation xml:lang="en">Sis B., Mengel M., Haas M. et al. Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups // Am. J. Transplant. 2010. Vol. 10. P. 464–471.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Smith R.N., Kawai T., Boskovic S. et al. Chronic antibody mediated rejection of renal allografts: Pathological, serological, and immunologic features in nonhuman primates // Am. J. Transplant. 2006. Vol. 6. P. 1790–1798.</mixed-citation><mixed-citation xml:lang="en">Smith R.N., Kawai T., Boskovic S. et al. Chronic antibody mediated rejection of renal allografts: Pathological, serological, and immunologic features in nonhuman primates // Am. J. Transplant. 2006. Vol. 6. P. 1790–1798.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Solez K., Axelsen R.A., Benediktsson H. et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology // Kidney Int. 1993. Vol. 44. Р. 411–422.</mixed-citation><mixed-citation xml:lang="en">Solez K., Axelsen R.A., Benediktsson H. et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology // Kidney Int. 1993. Vol. 44. Р. 411–422.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Suri D.L., Tomlanovich S.J., Olson J.L., Meyer T.W. Transplant glomerulopathy as a cause of late graft loss // Am. J. Kidney Dis. 2000. Vol. 35. P. 674–680.</mixed-citation><mixed-citation xml:lang="en">Suri D.L., Tomlanovich S.J., Olson J.L., Meyer T.W. Transplant glomerulopathy as a cause of late graft loss // Am. J. Kidney Dis. 2000. Vol. 35. P. 674–680.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Takemoto S.K., Zeevi A., Feng S. et al. National conference to assess antibody-mediated rejection in solid organ transplantation // Am. J. Transplant. 2004. Vol. 4. P. 1033–1041.</mixed-citation><mixed-citation xml:lang="en">Takemoto S.K., Zeevi A., Feng S. et al. National conference to assess antibody-mediated rejection in solid organ transplantation // Am. J. Transplant. 2004. Vol. 4. P. 1033–1041.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Vongwiwatana A., Gourishankar S., Campbell P.M. et al. Peritubular capillary changes and C4d deposits are associated with transplant glomerulopathy but not IgA nephropathy // Am. J. Transplant. 2004. Vol. 4. P. 124–129.</mixed-citation><mixed-citation xml:lang="en">Vongwiwatana A., Gourishankar S., Campbell P.M. et al. Peritubular capillary changes and C4d deposits are associated with transplant glomerulopathy but not IgA nephropathy // Am. J. Transplant. 2004. Vol. 4. P. 124–129.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Wang R., Wang H., Chen J. et al. C4d deposition in allograft renal biopsies is an independent risk factor for graft failure // Nephrology. 2009. Vol. 14. Р. 527–532.</mixed-citation><mixed-citation xml:lang="en">Wang R., Wang H., Chen J. et al. C4d deposition in allograft renal biopsies is an independent risk factor for graft failure // Nephrology. 2009. Vol. 14. Р. 527–532.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
